Cargando…
Wild-type cutoff for Apramycin against Escherichia coli
BACKGROUND: Apramycin is used exclusively for the treatment of Escherichia coli (E.coli) infections in swine around the world since the early 1980s. Recently, many research papers have demonstrated that apramycin has significant in vitro activity against multidrug-resistant E.coli isolated in hospit...
Autores principales: | Yang, Yuqi, Xiao, Tianshi, Li, Jiarui, Cheng, Ping, Li, Fulei, Yu, Hongxiao, Liu, Ruimeng, Muhammad, Ishfaq, Zhang, Xiuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448428/ https://www.ncbi.nlm.nih.gov/pubmed/32847547 http://dx.doi.org/10.1186/s12917-020-02522-0 |
Ejemplares similares
-
Susceptibility breakpoint for Danofloxacin against swine Escherichia coli
por: Yang, Yuqi, et al.
Publicado: (2019) -
Prevalence and molecular epidemiology characteristics of carbapenem-resistant Escherichia coli in Heilongjiang Province, China
por: Cheng, Ping, et al.
Publicado: (2019) -
Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model
por: Yang, Yuqi, et al.
Publicado: (2021) -
Prevalence and Characteristic of Swine-Origin mcr-1-Positive Escherichia coli in Northeastern China
por: Cheng, Ping, et al.
Publicado: (2021) -
Characterization of Resistance Patterns and Detection of Apramycin Resistance Genes in Escherichia coli Isolated from Chicken Feces and Houseflies after Apramycin Administration
por: Zhang, Anyun, et al.
Publicado: (2018)